Relmada Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.8M | 1.3M | 3.00 |
| 2024-03-31 | $5.8M | 1.3M | 4.65 |
| 2023-12-31 | $5.4M | 1.3M | 4.14 |
| 2023-09-30 | $3.9M | 1.3M | 3.00 |
| 2023-06-30 | $3.2M | 1.3M | 2.46 |
| 2023-03-31 | $3.4M | 1.5M | 2.26 |
| 2022-12-31 | $5.3M | 1.5M | 3.49 |
| 2022-06-30 | $27M | 1.4M | 18.99 |
| 2022-03-31 | $36M | 1.3M | 26.99 |
| 2021-09-30 | $24M | 915k | 26.21 |
| 2021-06-30 | $25M | 772k | 32.03 |
| 2021-03-31 | $24M | 693k | 35.22 |
| 2020-12-31 | $21M | 663k | 32.08 |
| 2020-09-30 | $25M | 673k | 37.62 |
| 2020-06-30 | $31M | 692k | 44.75 |
| 2020-03-31 | $20M | 580k | 34.11 |
| 2019-12-31 | $22M | 570k | 39.00 |